Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05044988
What this trial is testing

HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer

Who this might be right for
HR+/HER2- Advanced and/or Metastatic Breast Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT05789303
What this trial is testing

Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
University of Chicago 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT03964727
What this trial is testing

Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumor
Gilead Sciences 227
Testing effectiveness (Phase 2)Active Not RecruitingNCT06172127
What this trial is testing

PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
MedSIR 165
Post-approval studies (Phase 4)Study completedNCT02155517
What this trial is testing

Clinical Effect of Two Pharmacokinetics Model of Propofol

Who this might be right for
Healthy
Tiva Group 10
Testing effectiveness (Phase 2)Looking for participantsNCT06516289
What this trial is testing

Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab

Who this might be right for
BRCA-Mutated Breast CarcinomaHER2-negative Breast Cancer
Fudan University 130
Testing effectiveness (Phase 2)Study completedNCT01355289
What this trial is testing

Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501

Who this might be right for
Thrombocytopenia
Eisai Inc. 65
Testing effectiveness (Phase 2)UnknownNCT04984018
What this trial is testing

Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 73
Testing effectiveness (Phase 2)Looking for participantsNCT06254690
What this trial is testing

The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 102
Testing effectiveness (Phase 2)Study completedNCT02771197
What this trial is testing

Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant

Who this might be right for
Acute Myeloid Leukemia
Northside Hospital, Inc. 20
Large-scale testing (Phase 3)Looking for participantsNCT05899010
What this trial is testing

MIcronized PROgesterone in Frozen Embryo Transfer Cycles

Who this might be right for
Infertility
Fundación Santiago Dexeus Font 1,020
Not applicableActive Not RecruitingNCT04472910
What this trial is testing

GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma

Who this might be right for
Resectable Pancreatic Cancer
University Health Network, Toronto 84
Testing effectiveness (Phase 2)Study completedNCT00799513
What this trial is testing

Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
IRCCS San Raffaele 48
Testing effectiveness (Phase 2)Ended earlyNCT04964960
What this trial is testing

Pembro+Chemo in Brain Mets

Who this might be right for
Lung CancerLung Cancer MetastaticBrain Cancer+1 more
John L. Villano, MD, PhD 3
Testing effectiveness (Phase 2)Study completedNCT01380782
What this trial is testing

BIBF 1120 for Recurrent High-Grade Gliomas

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more
Patrick Y. Wen, MD 37
Testing effectiveness (Phase 2)Study completedNCT00462423
What this trial is testing

Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study

Who this might be right for
Metastatic Malignant Melanoma
Lynn E. Spitler, MD 50
Testing effectiveness (Phase 2)Study completedNCT02202980
What this trial is testing

Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 273
Testing effectiveness (Phase 2)Study completedNCT00276679
What this trial is testing

Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Early research (Phase 1)Study completedNCT01590446
What this trial is testing

Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers

Who this might be right for
Achondroplasia
BioMarin Pharmaceutical 74
Testing effectiveness (Phase 2)Study completedNCT00000842
What this trial is testing

A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy

Who this might be right for
HIV InfectionsPeripheral Nervous System Disease
National Institute of Allergy and Infectious Diseases (NIAID) 270
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation